Faster in and faster out: Accelerating insulin absorption and action by insulin infusion site warming

Diabetes Technology and Therapeutics

Volumn 16, Issue 1, 2014, Pages 20-25

  Cengiz, Eda ^a   Weinzimer, Stuart A ^a   Sherr, Jennifer L ^a   Tichy, Eileen M ^a   Carria, Lori ^a   Cappiello, Darryll ^a   Steffen, Amy ^a   Tamborlane, William V ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN ASPART;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION SITE WARMING DEVICE; MALE; MEDICAL DEVICE; PRIORITY JOURNAL; TEMPERATURE;

ABSORPTION; ADOLESCENT; AREA UNDER CURVE; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEMOGLOBIN A, GLYCOSYLATED; HOT TEMPERATURE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN ASPART; INSULIN INFUSION SYSTEMS; MALE; REGIONAL BLOOD FLOW; SKIN TEMPERATURE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891878059     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0187     Document Type: Article

References (26)

1. Cengiz E, Weinzimer SA, Sherr JL, Cengiz E, Tichy E, Martin M, Carria L, Steffen A, Tamborlane WV: Acceleration of insulin pharmacodynamic profile by a novel insulin infusion site warming device. Pediatr Diabetes 2012;14:168-173.
2. Swan KL, Dziura JD, Steil GM, Voskanyan GR, Sikes KA, Steffen AT, Martin ML, Tamborlane WV, Weinzimer SA: Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy. Diabetes Care 2009;32:240-244.
3. Swan KL, Weinzimer SA, Dziura JD, Swan KL, Weinzimer SA, Dziura JD, Steil GM, Voskanyan GR, Steffen AT, Martin ML, Tamborlane WV: Effect of puberty on the pharmacodynamic and pharmacokinetic properties of insulin pump therapy in youth with type 1 diabetes. Diabetes Care 2008; 31:44-46.
4. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939.
5. Berger M, Cuppers HJ, Hegner H, Jorgens V, Berchtold P: Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care 1982;5:77-91. (Pubitemid 12132223)
6. Koivisto VA, Felig P: Alterations in insulin absorption and in blood glucose control associated with varying insulin injection sites in diabetic patients. Ann Intern Med 1980;92:59-61. (Pubitemid 10135224)
7. Sindelka G, Heinemann L, Berger M, Frenck W, Chantelau E: Effect of insulin concentration, subcutaneous fat thickness and skin temperature on subcutaneous insulin absorption in healthy subjects. Diabetologia 1994;37:377-380. (Pubitemid 24113569)
8. Raz I, Weiss R, Yegorchikov Y, Bitton G, Nagar R, Pesach B: Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, twoperiod, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion. Clin Ther 2009;31:980-987.
9. Petrofsky J, Paluso D, Anderson D, Swan K, Yim JE, Murugesan V, Chindam T, Goraksh N, Alshammari F, Lee H, Trivedi M, Hudlikar AN, Katrak V: The contribution of skin blood flow in warming the skin after the application of local heat; the duality of the Pennes heat equation. Med Eng Physics 2011;33:325-329.
10. Charkoudian N: Skin blood flow in adult human thermoregulation: How it works, when it does not, and why. Mayo Clin Proc 2003;78:603-612. (Pubitemid 36529901)
11. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-E223.
12. Greenhalgh DG, Lawless MB, Chew BB, Crone WA, Fein ME, Palmieri TL: Temperature threshold for burn injury: An oximeter safety study. J Burn Care Rehabil 2004;25:411-415. (Pubitemid 39315197)
13. Siekmann H: Recommended maximum temperatures for touchable surfaces. Appl Ergonom 1990;21:69-73. (Pubitemid 20155264)
14. Diller KR, Hayes LJ, Blake GK: Analysis of alternate models for simulating thermal burns. J Burn Care Rehabil 1991; 12:177-189.
15. Diller KR: Analysis of burns caused by long-term exposure to a heating pad. J Burn Care Rehabil 1991;12:214-217.
16. Heinemann L: Variability of insulin absorption and insulin action. Diabetes Technol Ther 2002;4:673-682. (Pubitemid 35283332)
17. Codner E, Soto N, Lopez P, Trejo L, Avila A, Eyzaguirre FC, Iniguez G, Cassorla F: Diagnostic criteria for polycystic ovary syndrome and ovarian morphology in women with type 1 diabetes mellitus. J Clin Endocrinol Metab 2006;91: 2250-2256. (Pubitemid 43855014)
18. Purnell JQ, Zinman B, Brunzell JD: The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: Results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study. Circulation 2013;127:180-187.
19. Vora JP, Burch A, Peters JR, Owens DR: Relationship between absorption of radiolabeled soluble insulin, subcutaneous blood flow, and anthropometry. Diabetes Care 1992;15: 1484-1493.
20. Heinemann L, Hompesch M, Flacke F, Simms P, Pohl R, Albus K, Pfu tzner A, Steiner S: Reduction of postprandial glycemic excursions in patients with type 1 diabetes: A novel human insulin formulation versus a rapid-acting insulin analog and regular human insulin. J Diabetes Sci Technol 2011;5:681-686.
21. Hompesch M, Muchmore DB, Morrow L, Ludington E, Vaughn DE: Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase. Diabetes Technol Ther 2012;14:218-224.
22. Hompesch M, Muchmore DB, Morrow L, Vaughn DE: Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase. Diabetes Care 2011;34:666-668.
23. Morrow L, Muchmore DB, Hompesch M, Ludington EA, Vaughn DE: Comparative pharmacokinetics and insulin action for three rapid-acting insulin analogs injected subcutaneously with and without hyaluronidase. Diabetes Care 2013;36:273-275.
24. Pettis RJ, Hirsch L, Kapitza C, Nosek L, Hovelmann U, Kurth HJ, Sutter DE, Harvey NG, Heinemann L: Microneedle-based intradermal versus subcutaneous administration of regular human insulin or insulin lispro: Pharmacokinetics and postprandial glycemic excursions in patients with type 1 diabetes. Diabetes Technol Ther 2011;13:443-450.
25. Boss AH, Petrucci R, Lorber D: Coverage of prandial insulin requirements by means of an ultra-rapid-acting inhaled insulin. J Diabetes Sci Technol 2012;6:773-779.
26. McVey E, Hirsch L, Sutter DE, Kapitza C, Dellweg S, Clair J, Rebrin K, Judge K, Pettis RJ: Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion. J Diabetes Sci Technol 2012;6:743-754.